QNRX Latest Headlines

QNRX Reaches Key Milestone with 4% and 5% Rapamycin Loadings: What This Means for Rare Disease Treatments

Market Chameleon (Tue, 11-Nov 10:32 AM)

QNRX Achieves Key Milestone: 4% and 5% Rapamycin Loads Unlock Clinical Pathways for Rare Disease Treatments

Market Chameleon (Tue, 11-Nov 9:08 AM)

Quoin Pharmaceuticals Gains FDA Orphan Drug Designation for QRX003: A Milestone for Rare Disease Treatment

Market Chameleon (Tue, 21-Oct 8:51 AM)

QNRX Attracts $104.5 Million Private Placement: Key Terms Suggest Strong Institutional Confidence

Market Chameleon (Fri, 10-Oct 10:28 AM)